The Leipzig Prospective Drug-Eluting Balloon-Registry　– Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons

The Leipzig Prospective Drug-Eluting Balloon-Registry　– Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons –

Published:2016 Issue:2 Volume:80 Page:379-386
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Uhlemann Madlen¹,Möbius-Winkler Sven²,Adam Jennifer¹,Erbs Sandra¹,Mangner Norman¹,Sandri Marcus¹,Boudriot Enno¹,Woinke Michael¹,Schuler Gerhard C.¹,Linke Axel¹

Affiliation:

1. Heart Centre, Department of Internal Medicine/Cardiology, University of Leipzig, University of Leipzig

2. Asklepios Clinic

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/2/80_CJ-14-1352/_pdf

Reference30 articles.

1. 1. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schomig A, et al. Drug eluting and bare metal stents in people with and without diabetes: Collaborative network meta-analysis. BMJ 2008; 337: a1331.

2. 2. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005; 293: 165–171.